Drug intelligence / Profile preview

brompheniramine + pseudoephedrine + dextromethorphan

Development stage
Approved
Modality
Small Molecules
Administration
Oral
01

Overview

**Brompheniramine + pseudoephedrine + dextromethorphan** is a fixed-dose combination medication containing three active ingredients: an antihistamine (brompheniramine), a decongestant (pseudoephedrine), and a cough suppressant (dextromethorphan). It is used for the symptomatic relief of upper respiratory symptoms associated with allergies or the common cold, including cough, nasal congestion, runny nose, sneezing, and watery eyes[1][2][3]. **Mechanism of action:** *Brompheniramine* is an H1-receptor antagonist that blocks histamine at H1 receptors on effector cells in the respiratory tract, blood vessels, and GI tract. It also has anticholinergic effects that help dry secretions[4]. *Pseudoephedrine* acts as a sympathomimetic agent primarily on alpha-sympathetic receptors to cause vasoconstriction in nasal mucosa, reducing swelling and congestion[4]. *Dextromethorphan* acts centrally on the medullary cough center to suppress the cough reflex without analgesic or addictive properties[4]. The combination does not treat infections but provides short-term relief from allergy or cold symptoms.

Brand names
Bromfed DMAnaplex DMAndehist DMAndehist DM NRBrom/PSE/DM CoughBromaline DMBromatane DXBromaxefed DM RFBromdex DBrometane DXBromfed-DMBromophed DXBromphenex DMBromplex DMBrotapp-DMBroveX PSB DMCarbofed DMCardec DMDallergy DMDecon DMDimetane DXDimetapp Children's DM Cold and CoughDynatussEndaCof-DMLoHist PSB DMMyphetane DXNeo DMPBM AllergyQ-Tapp DMRobitussin Cough and AllergyRondamine DMRondec DMSildec DMTuss Mine DM
Other names
brompheniramine + pseudoephedrine + dextromethorphanbrompheniramine maleate + pseudoephedrine HCl + dextromethorphan HBr
02

Targets

ADRA1A (α1A)SIGMAR1 (Sigma non-opioid intracellular receptor 1)NMDAR (Glutamate receptor ionotropic, NMDA)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on brompheniramine + pseudoephedrine + dextromethorphan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on brompheniramine + pseudoephedrine + dextromethorphan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call